Thank you for submitting your manuscript for consideration by the EMBO Journal. It has now been seen by three referees whose comments are enclosed. As you will see, all three reviewers express significant interest in your work and are in favour of publication here, pending satisfactory revision. Many of their concerns can be addressed by amendments to the text, although referee 1 in particular raises a number of points that will require some additional experimental analysis.
I would therefore like to invite you to submit a revised version of the manuscript, addressing the comments of all three reviewers. I should add that it is EMBO Journal policy to allow only a single round of revision, and acceptance of your manuscript will therefore depend on the completeness of your responses in this revised version. When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://www.nature.com/emboj/about/process.html
We generally allow three months as standard revision time. As a matter of policy, competing manuscripts published during this period will not negatively impact on our assessment of the conceptual advance presented by your study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed. Should you foresee a problem in meeting this three-month deadline, please let us know in advance and we may be able to grant an extension.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely, Editor
The EMBO Journal REFEREE REPORTS Referee #1 (Remarks to the Author):
The manuscript by Cava et al reports a great number of data on the abundance, mechanism and regulation of D-amino acid modification in bacterial peptidoglycan, a cell wall polymer essential to maintain osmotic stability. Interestingly, they found two different ways of D-amino acid incorporation, one at the polymerized peptidoglycan catalysed by L,D-transpeptidases, and another by incorporating D-amino acid into peptidoglycan precursor. Different bacteria utilize one or both of these pathways. Interestingly, D-amino acid incorporation in V. cholerae appears regulated by RpoS. Most of the data presented are convincing. I have the following points to be considered by the authors:
Main points:
1. throughout the manuscript: the nomenclature of muropeptides and peptidoglycan precursors is odd and does not follow the one normally used in the field. It is also confusing at times, for example the term "muro-3" is sometimes used as GlcNAc-MurNAc-tripeptide (in muropeptides) and sometimes as MurNAc-tripeptide (in "UDP-muro3"). Therefore, I would recommend to use the generally accepted nomenclature for muropeptides and precursors and not to invent another, confusing system.
2. The finding of at least two different ways to incorporate D-amino acids has an important aspect that is not discussed: While Ldt-catalysed incorporation could occur at any growth phase (and occurs mainly in stationary, resting cells in Vibrio) the incorporation via precursor modification can occur only in growing cells as it requires incorporation of the precursors into the peptidoglycan; this is know to be significantly reduced in resting cells. To support the existence of this second pathway have the authors considered to extract and analyse the precursors from cells grown in the presence of D-Met (for Caulobacter) to see whether or not there are D-Met modified percursors? This would be important in particular as the in vitro data are not very convincing (there is only 1.2% product formation at one condition, Fig. 4c) 3. p. 15: The fact that D-cycloserine reduces the amount of pentapeptides with D-Met does not exclude the possibility that these structures are produced by an D-Ala -D-Met exchange reaction at position 5 (similar to the exchange reaction at position 4 by Ldt). This is because D-cycloserine also reduces normal pentapeptides that would be the substrate for the exchange reaction. The fact that modified pentapeptides are so scarce is seen to support a mechanism other than exchange (as written on p. 13), but this is not correct either, because the exchange reaction could be of low efficiency.
4. Measurement of the amount of peptidoglycan per cell ( Fig. 5 and S6 ). This is not trivial but crucial to some of the conclusions. The method is not properly described and so I cannot judge the data. You refer to a paper from the year 1958 which describes the separation of mesodiaminopimelic acid by paper chromatography (Meadow and Work). Has this been used his to semiquantitatively determine meso-diaminopimelic acid? I would assume the peptidoglycan has been hydrolysed before separating meso-diaminopimelic acid, but this is not reported. A detailed description of the method to quantify the amount of peptidoglycan per cell has to be added.
5. Also, because the peptidoglycan of the mutant is obviously different in certain aspects (strength), how can you then exclude that you have different amounts of material being lost during preparation (you unavoidably lose a fraction of the peptidoglycan during the preparation due to the many centrifugation steps)? Thus, there could be a general problem with determining the amount of peptidoglycan per cell by quantifying the purified peptidoglycan. The more recent literature contains much more reliable methods for quantification of peptidoglycan in cells, including radioactive labelling methods.
6. Survival of osmotically shocked stationary mutant cells (Fig. 5B ) and the conclusion that the effects are due to the absence of D-amino acid modification rather than the absence of DAP-DAP crosslinks and Lpp attachment (p. 17, and Discussion p. 20) . I agree that the bsrV mutant has similar percentage of survival than the ldtA LdtB bsrV triple mutant, but the values are very low (>10%) and so the conclusion is not convincing. You should use intermediate shock conditions, at which survival of the bsrV mutant is 50-80%, to test if the triple mutant has reduced survival.
Minor points:
7. p. 8: "The peptidoglycan of vc1268 is devoid of DAP-DAP crosslinks" To me the profile of vc1268 looks very similar to that of wt (Fig. S3a) ; could you indicate with arrows in Fig S3a which peaks are missing in the ldcA and ldcB mutant? 8. p. 12: "D-Pro is an imino acid" This is not correct because proline does not contain an imino (>C=NH) group (i.e. a C=N double bond). Rather, proline has a secondary amino group.
9. The method for muropeptide purification needs to be described. 18. Suppl. Legends Table S4 : should be "N-acetylmuramitol" and "N-acetylmuramic acid" Referee #2 (Remarks to the Author):
The authors have produced a beautifully written and well presented manuscript describing the biochemical pathways by which bacteria incorporate unusual D-amino acids into their cell wall peptidoglycan. Although the existence of such incorporation has been observed previously, not until now have the reaction mechanisms and physiological import been described. The experiments are well crafted, logically explicated and the potential biological implications are outlined very nicely.
Minor comments p 8 bottom paragraph ... The description of the mutants is confusing because the terminology in the text is not the same as that used to describe the mutants in the Figure. Please make the two coincide for the Reader's sake. show that D-met can be incorporated at two different positions in PG (4th and 5th) and that two L,D-transpeptidases can catalyze the incorporation at position 4 whereas incorporation at position 5 depends on the formation of an altered version of the lipid II precursor. Both pathways are reconstituted in vitro and evidence is presented that a third way to incorporate NCDAA into PG must exist. The authors show that NCDAA production is controlled by RpoS. The authors speculate about the role of NCDAA -one possibility the authors do not mention is that NCDAA may play a role in avoidance of recognition of PG fragments by the immune system. This paper provides a significant step forward in our understanding of bacterial cell wall metabolism. The paper is clearly written and the experiments are well executed. I fully support publication in the EMBO Journal. Main points:
Throughout the manuscript: the nomenclature of muropeptides and peptidoglycan precursors is odd and does not follow the one normally used in the field. It is also confusing at times, for example the term "muro-3" is sometimes used as GlcNAc-MurNAc-tripeptide (in muropeptides) and sometimes as MurNAc-tripeptide (in "UDP-muro3"). Therefore, I would recommend to use the generally accepted nomenclature for muropeptides and precursors and not to invent another, confusing system.
Response: We appreciate the referee's comment. We chose this nomenclature since in most cases we refer to a group of muropeptides (instead of single ones) which comprise both monomer, dimer and anhydro-muropeptide. For simplicity such groups have been named with the prefix "muro". Nevertheless, to avoid confusion between disaccharide-muropeptides and UDP-muramyl peptides we have changed the following nomenclature in the text and also in figures 4BC and S5: UDPmono3>UDP-M3; UDP-mono5>UDP-M5; and UDP-mono5M by UDP-M5. We attempted without success to purify D-Met modified precursors from Caulobacter as suggested; this is by no means a trivial task, since the C-terminal NCDAA within the peptide moiety of the precursor prevents the use of affinity purification by vancomycin modified resins. However, the data from the in vitro reactions are robust. It is critical to note that the 1.2% yield is not relative to a 100% yield; instead with the more common (D-Ala, not D-Met) substrate, the yield is only 9% (Fig  4C) . Response: The referee raises a valid point, and we have toned down (pag14, lines 17-18; and last line of page 20) this conclusion in the manuscript. However, several results argue against the alternative (exchange) mechanism proposed by the reviewer:. 1. V. cholerae has low levels (below 1%) of pentapeptides in mature PG both in log phase and in stationary phase. Thus, the abundance of mature pentapeptides present in log phase is insufficient to give rise to the level of muro5 M seen, particularly if the exchange reaction is inefficient, as the reviewer suggests. 2. Although the reviewer suggests that inhibition of precursor synthesis could indirectly effect incorporation of NCDAAs at the 5 th position via the exchange reaction, due to reduced production of substrates, our results argue against such events. In B. subtilis, effective inhibition of precursor synthesis did not reduce muro5 M abundance, presumably because muro5 M formation in B. subtilis is (as we suggest) mediated by a periplasmic, PBPdependent process. 3. We have reconstituted synthesis of the muro5 M precursors in vitro. This reaction is not efficient, and D-Met does not appear to be a preferred substrate; however, given the low levels of muro5 M seen in vivo such inefficiency is not surprising. Furthermore, preliminary data for an additional manuscript demonstrates a correlation between the extent of muro5 M accumulation in vivo in V. cholerae and E. coli (not seen in E coli) and the amounts of UDP-M5 that can be synthesized by purified Ddl and MurF from each organism in vitro (no synthesis from E. coli enzymes), suggesting that the in vitro reaction does reflect activity in vivo. 4. Finally, we have performed a new experiment to test NCDAA incorporation through periplasmic exchange vs cytosolic biosynthesis. V. cholerae grown overnight (i.e into stationary phase) with exogenous D-Met (5mM) was then shifted to a 6h exposure to exogenous D-Ala (10mM). PG analysis from both stationary phase cultures, incubated with or without with D-Ala showed a reduction in muro4 M in the D-Ala treated sample (7% decrease) whereas muro5 M muropeptides were barely affected (0.69% decrease). These data strongly support our idea that incorporation in 4 th position of the peptide moiety within muropeptides occurs through a C-terminal D-amino acid exchange reaction, whereas incorporation in the 5 th position is not mediated by a periplasmic exchange reaction. Instead, incorporation in the 5 th position is likely mediated by cytosolic synthetic enzymes which generate PG precursors.
The finding of at least two different ways to incorporate D-amino acids has an important aspect

p. 15: The fact that D-cycloserine reduces the amount of pentapeptides with D-Met does not exclude the possibility that these structures are produced by an D-Ala-D-Met exchange reaction at position 5 (similar to the exchange reaction at position 4 by Ldt
Measurement of the amount of peptidoglycan per cell (Fig. 5 and S6). This is not trivial but crucial to some of the conclusions. The method is not properly described and so I cannot judge the data. You refer to a paper from the year 1958 which describes the separation of mesodiaminopimelic acid by paper chromatography (Meadow and Work). Has this been used his to semiquantitatively determine meso-diaminopimelic acid? I would assume the peptidoglycan has been hydrolysed before separating meso-diaminopimelic acid, but this is not reported. A detailed description of the method to quantify the amount of peptidoglycan per cell has to be added.
Response: The referee is correct; there was a mistake in the citation. The appropriate reference is now included (Work. E. The Biochemical Journal. 1957. (67) 416-423). We now provide additional detail regarding our method to quantify PG (see "Quantification of total murein" section in materials and methods (pages 23 and 24).
Also, because the peptidoglycan of the mutant is obviously different in certain aspects (strength), how can you then exclude that you have different amounts of material being lost during preparation (you unavoidably lose a fraction of the peptidoglycan during the preparation due to the many centrifugation steps)? Thus, there could be a general problem with determining the amount of peptidoglycan per cell by quantifying the purified peptidoglycan. The more recent literature contains much more reliable methods for quantification of peptidoglycan in cells, including radioactive labelling methods.
Response: Past analyses (i.e. J. Bacteriol. Dec. 1991, p.7684-7691) in which radioactively labeled PG ([3H]Dap) was added to samples prior centrifugation to monitor the recovery of the PG throughout the procedure revealed that the method we use is reliable in terms of material recovery. Furthermore, in this particular case, even though the mutant PG is weaker, more PG is recovered from the mutant than from the wt in stationary phase; thus, if weakness impairs purification, our results are likely to underestimate rather than overestimate the different amounts of PG in wt vs mutant. (Fig. 5B ) and the conclusion that the effects are due to the absence of D-amino acid modification rather than the absence of and Discussion p. 20) Response: The reduction of viability due to osmotic shock does not have a linear correlation with the concentration of salt assayed. For this reason, the experiment has been optimized to compare the viability of wt and mutant strains and as shown in Fig. 5B the results are statistically robust.
Survival of osmotically shocked stationary mutant cells
Minor points: (Fig. S3a) ; could you indicate with arrows in Fig S3a which peaks are missing in the ldtA and ldtB mutant?
p. 8: "The peptidoglycan of vc1268 is devoid of DAP-DAP crosslinks" To me the profile of vc1268 looks very similar to that of wt
Response: We have indicated the corresponding mobility of the peaks in figure S3A . For Muro-Lpp we have indicated only mono3-Lpp since di4,3-Lpp is very minor and cannot be appreciated in the graph.
p. 12: "D-Pro is an imino acid" This is not correct because proline does not contain an imino (>C=NH) group (i.e. a C=N double bond). Rather, proline has a secondary amino group.
Response: We have adopted the referee's suggestion: "D-Pro, which has a secondary amino group" (page 12, line 10).
The method for muropeptide purification needs to be described.
Response: We now include this information in the methods section as suggested (p. 25, lines 1-3).
p. 25. in vitro synthesis of UDP-MurNAc pentapeptide(D-Met). The product peak is very small. How was the identity of this product confirmed? Did you perform MS, or did you shift the product with H2O2?
Response: The retention time of the D-Met containing precursor was initially identified by a shift in mobility after oxidation by H 2 O 2 . Additionally, its identity was confirmed by electrospray ion trap MS/MS as mentioned in the text (page 14, line 14).
Fig. S4c. The figure is confusing. You have to show the chromatograms with and without the enzyme, not showing the "direction of the reaction" in the single chromatograms.
Response: To avoid unnecessary complication in figure S4C we have not included the chromatograms with enzyme at time 0 nor chromatograms with no enzyme added. However, those chromatograms were used to calculate the % of product yielded by the reaction (Fig.3A) . Response: 10% activity corresponds to a 30 min experiment in fig3a (mentioned on page 24, line 20), whereas 80% (fig 3b) activity corresponds to a 2h experiment; we have now clarified the incubation times in the corresponding figure legend. Fig3 reactions are performed in an optimized buffer at pH7.5 where as the one in FigS4a showing only 30% activity (at 2h) was done at pH7. We have also included the activity data from reactions in buffer phosphate pH 7.5 (80%) in a new figS4. 100% in figS5b corresponds to a normalization of the activity obtain with the wt LdtA protein compared to the LdtA mutant.
The ms presents four different values for the activity of
Fig. 4e: Does penicillin block D-Met incorporation in C. crescentus?
Response: We do not know for sure. This experiment has been done but C. crescentus strain CB15N is very sensitive to the concentrations of Penicillin, even in the transition to stationary phase. PG recovery was too low to be used for accurate quantification.
14. The Fig. S5 appears strangely mixed of parts that do not fit together. Part C should be shown as an extra suppl. figure. Response: We think that the illustration in panel C of figure 5 helps the reader to understand the data shown in panel D.
Fig. S5B. Did the mutated LdtA contain three amino acid exchanges? Why not exchange just the catalytic cysteine?
Response: We just wanted to create an inactive mutant as a negative control for the reaction. In order to achieve this, we mutated the three conserved residues within this active site. Since there is knowledge of the catalytic sequences of these proteins, we speculated that this Ldt also has a Cys as a catalytic residue rather than a Ser but we have not confirmed this.
p. 15: what is the evidence that "penicillin G cannot penetrate the inner bacterial membrane"? A reference should be provided or this statement should be removed.
Response: The statement has been removed.
Fig. S7 is not very informative and can be removed.
Response: We think that this supplemental figure might help the reader to visualize the structural differences between canonical muropeptides and muropeptides modified with NCDAAs (i.e DMethionine) and therefore how this may influence PG synthetic and modifying enzymes. Table S4 : should be " N-acetylmuramitol" and "N-acetylmuramic acid" Response: Corrected as suggested.
Suppl. Legends
Referee #2 (Remarks to the Author):
The Response: As detailed in materials and methods (page 24, line 3-4), PG quantification is calculated by cfu normalization. All V. cholerae strains used in this work showed similar sizes and morphologies. Fig 2B versus 2D Mohammadi et al. EMBO Journal (2011 ) 30, 1425 -1432 Response: We included the indicated reference (page 4, line 2). Hasegawa et al. (2003) . FEMS Microbiol Lett 223, 41-46 and Wainwright et al. (2002) . Med Hypotheses 58, [558] [559] [560] Response: For fig.1 experiment we have used Corning 0.22mm polyethersulfone filters. Initially we inoculated V. cholerae only in one of the two compartments and found that after overnight incubation there were no signs of contamination in the other compartment. The passage of small molecules was confirmed with food coloring as positive control. Response: The referee is right but we think the most important data regarding the activity of LdtA and LdtB comes from the mutant analysis. We do not know if the activity of LdtB in overexpression experiments might be limited by some other factors (i.e interacting protein partners); therefore we cannot speculate much about the contribution of each in the global editing of muropeptides by NCDAAs. Many thanks for submitting the revised version of your manuscript EMBOJ-2011-77936R. It has now been seen again by referee 1, whose comments are enclosed below. As you will see, he/she finds the manuscript to be well revised and finds the study suitable for publication without further revision. I am therefore pleased to be able to tell you that we can accept your study to be published here. However, I do just have one issue from the editorial side first. You state in the Materials and Methods that the data presented in figures 1-4 show representative experiments, but do not state how often you have replicated these results. I don't know whether the experiments are directly comparable, but if you can show mean ± error for these experiments, I would encourage you to do so. If not, please can you state clearly in the figure legends that the 'data shown are representative of x independent experiments'?
If you can just make these final changes and resubmit the manuscript, we should be able to accept it without further delay.
Many thanks and best wishes,
Editor
The EMBO Journal REFEREE REPORT Referee #1 (Remarks to the Author):
The authors have addressed to my satisfaction all points I have raised on the first version of their
